
|Articles|November 16, 2017
Singapore Market Expects to Reach $1.15 billion by 2021
Advertisement
The Singapore pharmaceutical market is predicted to grow from $903 million in 2016 to $1.15 billion by 2012, according to data and analytics company GlobalData.
The company’s latest report shows that a key driver in Singapore’s healthcare market is universal access to health insurance and world-class biomedical sciences research facilities.
The medical device market is expected to grow as Singapore strengthens its position as the region’s healthcare hub. In 2015, the medical device market contributed $1.69 billion to Singapore’s output.
View the full report
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
What Kinds of Disruption are GLP-1s Expected to Face
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
The Evolving Relationship Between FDA and Biotech
5




